Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Egypt · Delayed Price · Currency is EGP

373.00

+11.02 (3.04%)

At close: Nov 12, 2026

Market Cap	8.49B +89.3%
Revenue (ttm)	1.71B +13.1%
Net Income	479.96M -5.0%
EPS	21.10 -5.0%
Shares Out	22.75M
PE Ratio	17.68
Forward PE	n/a
Dividend	13.19 (3.54%)
Ex-Dividend Date	Nov 26, 2026

Volume	520,495
Open	361.98
Previous Close	361.98
Day's Range	355.02 - 374.98
52-Week Range	130.00 - 490.86
Beta	0.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries engages in the research and development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, central nervous system, dermatological, cardiovascular diseases, vitamins and minerals, analgesics and antipyretics, respiratory system, and gastrointestinal and metabolic disorders. It also provides products for anthelmintic, anti-hyperte... [Read more]

Industry Pharmaceutical Preparations

Founded 1940

Employees 144

Stock Exchange Egyptian Stock Exchange

Ticker Symbol MPCI

Full Company Profile

Financial Performance

In fiscal year 2026, EGX:MPCI's revenue was 1.71 billion, an increase of 13.14% compared to the previous year's 1.51 billion. Earnings were 479.96 million, a decrease of -5.01%.

Financial Statements